Overview

Synergistic Effect of Vedolizumab and Pentoxifylline

Status:
Completed
Trial end date:
2019-06-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the synergistic effect and clinical benefits of vedolizumab and pentoxifylline in the management of patients with inflammatory bowel disease.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Miami
Collaborator:
Takeda
Treatments:
Pentoxifylline
Vedolizumab